Skip to main content

Siemens Healthcare Diagnostics, Inc.

Siemens Healthcare Diagnostics, Inc.: 11 recalls listed since March 2026 across FDA.

By year

  • 202611

By agency

  • FDA11

By category

  • Medical Device11

All recalls (11)

Atellica CH Revised C-Reactive Protein (RCRP)

The potential for falsely elevated results.

Moderate risk, FDA, , Device defect

Siemens Healthcare Diagnostics Beckman Coulter and Syva EMIT 2000 Quinidine Assay

The Syva EMIT 2000 Quinidine Assay has unacceptable precision, leading to erroneously elevated quinidine measurements.

Moderate risk, FDA, , Device defect

Siemens Healthcare Diagnostics Atellica CH Urine Albumin

Atellica CH Urine Albumin tests may cause falsely depressed urea nitrogen and hemoglobin A1c results.

Moderate risk, FDA, , Device defect

Syva Emit Tox Serum Tricyclic Antidepressant Calibrator/Controls

Syva Emit tox Serum Tricyclic Antidepressant Calibrator/Controls have out-of-specification sodium azide concentration, causing low health risk.

Low risk, FDA, , Quality testing problem

Syva Emit Disopyramide Assay Enzyme Immunoassay

The Syva Emit Disopyramide Assay has an out-of-specification sodium azide concentration, which can cause mild skin or eye irritation.

Low risk, FDA, , Quality testing problem

Atellica CH Enzymatic Hemoglobin A1c (A1c_E)

The assay has a potential for intermittent well-to-well bias.

Moderate risk, FDA, , Device defect

Siemens Dimension Tacrolimus Flex Reagent Cartridge (TAC)

A potential positive bias in quality control (QC) and patient sample results in three lots of the Dimension Tacrolimus (TAC) Flex reagent cartridge.

Moderate risk, FDA, , Device defect

Siemens Epoc BGEM BUN Test Cards

The affected product can result in discrepant low pH and measured Total Carbon Dioxide results.

Moderate risk, FDA, , Device defect

Siemens Healthcare Diagnostics Dimension Creatinine Flex Reagent Cartridge

This imprecision may lead to erroneously decreased or increased creatinine patient results.

Moderate risk, FDA, , Device defect

Atellica CH Enzymatic Hemoglobin A1c (A1c_E)

Atellica CH Enzymatic Hemoglobin A1c (A1c_E) may show depressed results when used with RCRP on the same analyzer, potentially delaying diabetes diagnosis.

Moderate risk, FDA, , Device defect

Atellica CH Urine Albumin (UAlb)

Atellica CH Urine Albumin may report falsely depressed results for samples above 40.0 mg/dL.

Moderate risk, FDA, , Device defect
Embed this list